415 related articles for article (PubMed ID: 38673047)
21. Circulating Tumor DNA Clinical Applications in Hepatocellular Carcinoma: Current Trends and Future Perspectives.
Bardol T; Pageaux GP; Assenat E; Alix-Panabières C
Clin Chem; 2024 Jan; 70(1):33-48. PubMed ID: 37962158
[TBL] [Abstract][Full Text] [Related]
22. Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy.
Maravelia P; Silva DN; Rovesti G; Chrobok M; Stål P; Lu YC; Pasetto A
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503144
[TBL] [Abstract][Full Text] [Related]
23. Tumor educated platelets, a promising source for early detection of hepatocellular carcinoma: Liquid biopsy an alternative approach to tissue biopsy.
Asghar S; Waqar W; Umar M; Manzoor S
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):836-844. PubMed ID: 32312598
[TBL] [Abstract][Full Text] [Related]
24. Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma.
Choi EJ; Kim YJ
J Liver Cancer; 2022 Sep; 22(2):103-114. PubMed ID: 37383403
[TBL] [Abstract][Full Text] [Related]
25. Application of the Multi-Omics Liquid Biopsy Method M2P-HCC in Early Liver Cancer Screening for High-Risk Individuals with Hepatitis B-Related Liver Cancer.
Yu X; Lei X
Diagnostics (Basel); 2023 Jul; 13(15):. PubMed ID: 37568847
[TBL] [Abstract][Full Text] [Related]
26. [Current Status and Prospects of Liquid Biopsy for Hepatocellular Carcinoma].
Kang J; Kim SS
Korean J Gastroenterol; 2023 Jul; 82(1):1-9. PubMed ID: 37489076
[TBL] [Abstract][Full Text] [Related]
27. Application of a novel liquid biopsy in patients with hepatocellular carcinoma undergoing liver transplantation.
Xue F; Shi S; Zhang Z; Xu C; Zheng J; Qin T; Qian Z; Zhao X; Tong Y; Xia L; Xia Q
Oncol Lett; 2018 Apr; 15(4):5481-5488. PubMed ID: 29552189
[TBL] [Abstract][Full Text] [Related]
28. Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal.
Espejo-Cruz ML; González-Rubio S; Zamora-Olaya J; Amado-Torres V; Alejandre R; Sánchez-Frías M; Ciria R; De la Mata M; Rodríguez-Perálvarez M; Ferrín G
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884878
[TBL] [Abstract][Full Text] [Related]
29. Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?
Mocan T; Simão AL; Castro RE; Rodrigues CMP; Słomka A; Wang B; Strassburg C; Wöhler A; Willms AG; Kornek M
J Clin Med; 2020 May; 9(5):. PubMed ID: 32443747
[TBL] [Abstract][Full Text] [Related]
30. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes.
Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L
Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189
[No Abstract] [Full Text] [Related]
31. Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer.
Zhou H; Zhu L; Song J; Wang G; Li P; Li W; Luo P; Sun X; Wu J; Liu Y; Zhu S; Zhang Y
Mol Cancer; 2022 Mar; 21(1):86. PubMed ID: 35337361
[TBL] [Abstract][Full Text] [Related]
32. Liquid biopsy in breast cancer: A comprehensive review.
Alimirzaie S; Bagherzadeh M; Akbari MR
Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
[TBL] [Abstract][Full Text] [Related]
33. Liquid biopsies for hepatocellular carcinoma.
Su YH; Kim AK; Jain S
Transl Res; 2018 Nov; 201():84-97. PubMed ID: 30056068
[TBL] [Abstract][Full Text] [Related]
34. A clinically feasible circulating tumor cell sorting system for monitoring the progression of advanced hepatocellular carcinoma.
Huang XY; Li F; Li TT; Zhang JT; Shi XJ; Huang XY; Zhou J; Tang ZY; Huang ZL
J Nanobiotechnology; 2023 Jan; 21(1):25. PubMed ID: 36681851
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma.
Cheng Y; Luo L; Zhang J; Zhou M; Tang Y; He G; Lu Y; Wang Z; Pan M
J Gastrointest Surg; 2019 Dec; 23(12):2354-2361. PubMed ID: 30805878
[TBL] [Abstract][Full Text] [Related]
36. Liquid Biopsy in Hepatocellular Carcinoma.
Zhou Z; Xu X; Liu Y; Liu Q; Zhang W; Wang K; Wang J; Yin Y
Methods Mol Biol; 2023; 2695():213-225. PubMed ID: 37450121
[TBL] [Abstract][Full Text] [Related]
37. Bioplatforms in liquid biopsy: advances in the techniques for isolation, characterization and clinical applications.
Shah UJ; Alsulimani A; Ahmad F; Mathkor DM; Alsaieedi A; Harakeh S; Nasiruddin M; Haque S
Biotechnol Genet Eng Rev; 2022 Oct; 38(2):339-383. PubMed ID: 35968863
[TBL] [Abstract][Full Text] [Related]
38. Using cell-free DNA for HCC surveillance and prognosis.
Tran NH; Kisiel J; Roberts LR
JHEP Rep; 2021 Aug; 3(4):100304. PubMed ID: 34136776
[TBL] [Abstract][Full Text] [Related]
39. The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma.
Pezzuto F; Buonaguro L; Buonaguro FM; Tornesello ML
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29597259
[TBL] [Abstract][Full Text] [Related]
40. Circulating tumor DNA/circulating tumor cells and the applicability in different causes induced hepatocellular carcinoma.
Li X; Wang H; Li T; Wang L; Wu X; Liu J; Xu Y; Wei W
Curr Probl Cancer; 2020 Apr; 44(2):100516. PubMed ID: 31836136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
